Rachel Hart
Geriatric Medicine · Louisville, KYNPI 1104192889
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,050 of the $34,349 with a category attached, or 72.9%. Lilly USA, LLC accounts for 99.7% of it on its own, with 1 other manufacturer making up the rest. 2025 is the largest year on record at $21,287, more than ten times the $21 reported in 2023. Among geriatric medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 59 payments — averaging $582.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$34K
- Novo Nordisk$120
What the payments were for
- Consulting fees$6,67519%
- Speaking & faculty fees$25,05073%
- Travel & lodging$1,8605%
- Food & beverage$7642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 58 | $34,229 |
| Novo Nordisk | 1 | $120 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$31,611
How this compares
$34,349 in reported general payments places this provider in the 95th percentile of 33 geriatric medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 758 | $24,273 |
| Donepezil Hcl | 839 | $8,776 |
| Rivastigmine | 38 | $7,549 |
| RivastigmineRivastigmine Tartrate | 103 | $6,363 |
| Memantine Hcl ErMemantine Hcl | 49 | $6,129 |
| Mirtazapine | 38 | $1,663 |
| Quetiapine Fumarate | 84 | $1,178 |
| Trazodone Hcl | 53 | $358 |
| Citalopram HbrCitalopram Hydrobromide | 49 | $287 |
| Sertraline Hcl | 41 | $253 |
| Buspirone Hcl | 11 | $66 |
| Lorazepam | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Louisville
- Josephine GomesLouisville$11K
- Svitlana MandzyLouisville$2K
- Christian FurmanLouisville$667
- Bhagyalaxmi RudravaramLouisville$370
- Kenneth PughLouisville$223
- Claudiu MoisaLouisville$168
- Arif NazirLouisville$87
- Kelly ChurchLouisville$29
- James ObrienLouisville$16
- Patrick MurphyLouisville$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.